SCHEMBL17851981

SCHEMBL17851981

CC1(C)c2cccc(-c3cccc(-c4c5ccccc5c(-c5ccc6oc7ccccc7c6c5)c5ccccc45)c3)c2-c2ccc3ccccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
ALOX5 P09917 1/20 0.33
KDM4E B2RXH2 6/20 0.32
ALDH1A1 P00352 5/20 0.32
MAPT P10636 5/20 0.32
HPGD P15428 4/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17851979 0.99 PLA2G2A (0.34) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851982 0.97 HSP90AA1 (0.33) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851980 0.97 HSP90AA1 (0.33) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851973 0.96 PLA2G2A (0.33) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851954 0.95 PLA2G2A (0.34) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851977 0.95 HSP90AA1 (0.35) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851952 0.94 HSP90AA1 (0.35) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851985 0.93 ABCG2 (0.33) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL17851975 0.92 HSP90AA1 (0.33) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1
SCHEMBL17851976 0.92 HSP90AA1 (0.34) HSP90AA1HSP90AB1ALOX5KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 HSP90AA1 4178/4885HSP90AB1 4422/4885ALOX5 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.